January 08, 2013 at 18:24 PM EST
Market Report, "Peru Pharmaceuticals & Healthcare Report Q4 2012", Published
Boston, MA -- (SBWIRE) -- 01/08/2013 -- BMI View: We continue to view Peru as a moderately attractive pharmaceutical market, on account of elevated risks posed by regulatory and intellectual property (IP) shortcomings and the still-developing healthcare infrastructure. Nevertheless, economic progress and the government-led investment in healthcare facilities and public health programmes pose upside risks to our current forecasts. We also expect Peru's pharmaceutical market to post a local currency compound annual growth rate (CAGR) of 7.6% in the 2011-2016 period, which is only slightly below that forecast for the country's healthcare spending and also in line with Peru's GDP development.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here